THE NKG2D SYSTEM MEDIATES ANTI-TUMOR EFFECTS OF CHEMOTHERAPY AND RADIOTHERAPY AGAINST GLIOBLASTOMA

被引：0
|
作者：
Weiss, T. [1 ,2 ,3 ]
Schneider, H. [1 ,2 ,3 ]
Silginer, M. [1 ,2 ,3 ]
Steinle, A. [4 ]
Pruschy, M. [3 ,5 ]
Weller, M. [1 ,2 ,3 ]
Roth, P. [1 ,2 ,3 ]
机构：
[1] Univ Hosp, Dept Neurol, Zurich, Switzerland
[2] Univ Hosp, Brain Tumor Ctr, Zurich, Switzerland
[3] Univ Zurich, Zurich, Switzerland
[4] Goethe Univ Frankfurt, Inst Mol Med, Frankfurt, Germany
[5] Univ Hosp, Dept Radiat Oncol, Zurich, Switzerland
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P08.22
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [21] TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses
    Harris, Rebecca
    Mammadli, Mahinbanu
    Hiner, Shannon
    Suo, Liye
    Yang, Qi
    Sen, Jyoti Misra
    Karimi, Mobin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1581 - 1601
  • [22] TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses
    Rebecca Harris
    Mahinbanu Mammadli
    Shannon Hiner
    Liye Suo
    Qi Yang
    Jyoti Misra Sen
    Mobin Karimi
    Cancer Immunology, Immunotherapy, 2023, 72 : 1581 - 1601
  • [23] Anti-tumor efficacy of chimeric NKG2D receptor-expressing T cells requires the induction of host immune responses
    Barber, Amorette
    Rynda, Agnieszka
    Zhang, Tong
    Sentman, Charles
    CANCER RESEARCH, 2009, 69
  • [24] Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications
    Lo, Carmen Sze-Ching
    Kiang, Karrie Mei-Yee
    Leung, Gilberto Ka-Kit
    LABORATORY INVESTIGATION, 2022, 102 (02) : 118 - 125
  • [25] Viral inhibitors of NKG2D ligands for tumor surveillance
    Chavez-Blanco, Alma
    Chacon-Salinas, Rommel
    Dominguez-Gomez, Guadalupe
    Gonzalez-Fierro, Aurora
    Perez-Cardenas, Enrique
    Taja-Chayeb, Lucia
    Trejo-Becerril, Catalina
    Duenas-Gonzalez, Alfonso
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (11) : 1375 - 1387
  • [26] ANTIBODY TARGETING NKG2D LIGANDS MICA/B TO UNLEASH ANTI-TUMOR IMMUNITY OF NK AND ILC1 CELLS
    Liu, Sizhe
    Smith, Tyler
    Zhu, Lisha
    Dhar, Payal
    Wu, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1054 - A1054
  • [27] NKG2D: A versatile player in the immune system
    Jelencic, Vedrana
    Lenartic, Maja
    Wensveen, Felix M.
    Polic, Bojan.
    IMMUNOLOGY LETTERS, 2017, 189 : 48 - 53
  • [28] MicroRNAs regulate NKG2D ligands on tumor cells
    Yadav, Deepak
    Ngolab, Jennifer
    Lim, Rod S.
    Krishnamurthy, Siddharth
    Bui, Jack D.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [29] New prospects on the NKG2D/NKG2DL system for oncology
    Ullrich, Evelyn
    Koch, Joachim
    Cerwenka, Adelheid
    Steinle, Alexander
    ONCOIMMUNOLOGY, 2013, 2 (10):
  • [30] Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
    Coudert, JD
    Zimmer, J
    Tomasello, E
    Cebecauer, M
    Colonna, M
    Vivier, E
    Held, W
    BLOOD, 2005, 106 (05) : 1711 - 1717
12345